Abstract
Activated recombinant factor VIIa was administered to a preterm infant with bleeding diasthesis and a huge subdural hematoma that could not be controlled by the blood products. The coagulation tests were normalized the following day. Recombinant factor VIIa can be a choice in selected cases with intractable bleedings unesponsive to conventional replacement therapy.
Original language | English (US) |
---|---|
Pages (from-to) | 627-629 |
Number of pages | 3 |
Journal | Journal of Maternal-Fetal and Neonatal Medicine |
Volume | 20 |
Issue number | 8 |
DOIs | |
State | Published - 2007 |
Externally published | Yes |
Keywords
- Bleeding diasthesis
- Factor VIIa
- Preterm
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Obstetrics and Gynecology